Literature DB >> 10150873

Risk factors for proliferative vitreoretinopathy.

H Nagasaki1, K Shinagawa.   

Abstract

Despite the recent progress in vitreous surgery, treatment of proliferative vitreoretinopathy (PVR) is still difficult. Even if the reattachment of the retina is successful, visual prognosis is often unsatisfactory. Identification of clinical risk factors for PVR provides useful guidelines for planning the management of rhegmatogeneous retinal detachment. This review summarized the current concept for pathogenesis, clinical risk factors, and medical treatment for PVR. The presence of retinal breaks and the breakdown of the blood-retinal barrier are prerequisite to development of PVR. Almost all risk factors for PVR are associated with intravitreal dispersion of retinal pigment epithelial cells or the breakdown of the blood-retinal barrier.

Entities:  

Mesh:

Year:  1995        PMID: 10150873     DOI: 10.1097/00055735-199506000-00012

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  5 in total

1.  Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy.

Authors:  I A El-Ghrably; H S Dua; G M Orr; D Fischer; P J Tighe
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR).

Authors:  Khaled Nassar; Julia Lüke; Matthias Lüke; Mahmoud Kamal; Effat Abd El-Nabi; Mahmoud Soliman; Martin Rohrbach; Salvatore Grisanti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-07-07       Impact factor: 3.117

3.  Detection of cytokine mRNA production in infiltrating cells in proliferative vitreoretinopathy using reverse transcription polymerase chain reaction.

Authors:  I A El-Ghrably; H S Dua; G M Orr; D Fischer; P J Tighe
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

4.  Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy.

Authors:  G A Limb; A H Chignell
Journal:  Br J Ophthalmol       Date:  1999-08       Impact factor: 4.638

5.  Anatomical and functional outcomes in combined rhegmatogenous retinal and choroidal detachment pre-treated with systemic corticosteroid: a case series.

Authors:  Fergus Doyle; David Keegan
Journal:  Ir J Med Sci       Date:  2021-09-06       Impact factor: 2.089

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.